EUVIMEDEUVIMED entdecken
Crossref

Real-time intraocular pressure monitoring and responsive drug release in preclinical models by an all-polymer smart contact lens

Yuting Cai iD, Chenguang Zhang iD, Pengrui Dang, Chenshu Liu iD, Yuxuan Du iD, Reihaneh Haghniaz, Jiechen Wang, Safoora Khosravi, Zhengtang Luo iD, Peyman Servati iD, Lili Chen iD, James S Wolffsohn iD und 2 weitere

Science Translational Medicine · 08.04.2026 · 18 (844)

DOI: 10.1126/scitranslmed.ads9541 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 08.04.2026. Verfasst von Yuting Cai und 13 weiteren Autor:innen. Beteiligte Einrichtung: Terasaki Institute for Biomedical Innovation, Los Angeles, CA 91367, USA. Hauptthemen laut MEDLINE: Intraocular Pressure, Contact Lenses, Polymers, Drug Liberation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Terasaki Institute for Biomedical Innovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glaucoma remains a leading cause of irreversible blindness worldwide, yet conventional topical therapies are often hampered by poor patient adherence, and standard in-office applanation tonometry captures only static measurements, failing to capture the dynamic nature of intraocular pressure (IOP). Smart contact lenses have emerged as promising tools for home-based, real-time IOP monitoring and feedback-guided therapy; however, most rely on bulky or rigid electronics that impair comfort, safety, and visual performance. Here, we report a battery-free, all-polymer microfluidic theranostic smart contact lens (AP-TSCL) that enables autonomous IOP-responsive glaucoma therapy without bulky electronic components. The AP-TSCL integrates a noninvasive microfluidic IOP sensor with a multistage, pressure-gated drug delivery architecture. Embedded microchannels define distinct activation thresholds, enabling lens deformation under elevated IOP to drive staged release from multiple drug reservoirs. Across in vitro (artificial eye model), ex vivo (enucleated bovine eyes), and in vivo (rabbit ocular hypertension) studies, the device achieved tonometry-aligned IOP tracking, pressure-triggered delivery of timolol or brimonidine above preset thresholds, and IOP lowering comparable to conventional topical therapy. This preclinical evidence suggests that the fully integrated platform may overcome key limitations of existing technologies and offers a clinically translatable solution for personalized ocular care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intraocular PressureContact LensesPolymersDrug LiberationAnimalsRabbitsCattleTimololTonometry, OcularGlaucomaDrug Delivery SystemsHumansBrimonidine Tartrate

Substanzen

PolymersTimololBrimonidine Tartrate

Autor:innen und Institutionen

  • Terasaki Institute for Biomedical Innovation, Los Angeles, CA 91367, USA.
  • Department of Chemical and Biological Engineering, William Mong Institute of Nano Science and Technology, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon 999077, Hong Kong, China.
  • Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Stomatology, Guangzhou 510055, China.
  • VIP Department, School and Hospital of Stomatology, China Medical University, Liaoning Provincial Key Laboratory of Oral Diseases, Shenyang, Liaoning 110002, China.
  • Department of Stomatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
  • Flexible Electronics and Energy Lab (FEEL), Department of Electrical and Computer Engineering, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.

ORCID-Profile: Yuting Cai, Chenguang Zhang, Chenshu Liu, Yuxuan Du, Zhengtang Luo, Peyman Servati, Lili Chen, James S Wolffsohn, Tae-Woo Lee, Yangzhi Zhu

Förderung

  • Terasaki Institute for Biomedical Innovation

Zitieren

APA

Cai, Y., Zhang, C., Dang, P., Liu, C., Du, Y., Haghniaz, R., Wang, J., Khosravi, S., Luo, Z., Servati, P., Chen, L., Wolffsohn, J. S., Lee, T. W., & Zhu, Y. (2026). Real-time intraocular pressure monitoring and responsive drug release in preclinical models by an all-polymer smart contact lens. Science Translational Medicine, 18(844). https://doi.org/10.1126/scitranslmed.ads9541

Vancouver

Cai Y, Zhang C, Dang P, Liu C, Du Y, Haghniaz R, et al. Real-time intraocular pressure monitoring and responsive drug release in preclinical models by an all-polymer smart contact lens. Science Translational Medicine. 2026;18(844). doi:10.1126/scitranslmed.ads9541

BibTeX
@article{Cai2026,
  author = {Cai, Yuting and Zhang, Chenguang and Dang, Pengrui and Liu, Chenshu and Du, Yuxuan and Haghniaz, Reihaneh and Wang, Jiechen and Khosravi, Safoora and Luo, Zhengtang and Servati, Peyman and Chen, Lili and Wolffsohn, James S and Lee, Tae-Woo and Zhu, Yangzhi},
  title = {Real-time intraocular pressure monitoring and responsive drug release in preclinical models by an all-polymer smart contact lens},
  journal = {Science Translational Medicine},
  year = {2026},
  volume = {18},
  number = {844},
  doi = {10.1126/scitranslmed.ads9541}
}
Kostenlos starten →